Avid Bioservices

Avid Bioservices, Inc. is a Contract Development and Manufacturing Organization (CDMO) that specializes in the development and cGMP manufacturing of biologics. Established in 1993 as Peregrine Pharmaceuticals, it became an independent entity in 2018 and is listed on NASDAQ under the ticker symbol CDMO. The company offers a wide range of services for the biotechnology and biopharmaceutical industries, including process development, cGMP manufacturing, quality and regulatory compliance, and analytical services. Avid Bioservices focuses on delivering personalized experiences to its clients, ensuring high-quality and reliable services. The company has made significant investments in expanding its facilities, including the opening of new production lines for viral vectors and mammalian proteins. With a strong commitment to quality and continuous improvement, Avid Bioservices collaborates with various partners in the industry to support the development of biologics used in therapeutic applications worldwide.